Get News Updates

Scientific Sessions Home

Register Now

MENUCLOSE
  • Home
  • News Archive
    • 85th Scientific Sessions (2025)
      • Planning Resources
      • Presenter Profiles
      • Session Coverage
    • 84th Scientific Sessions (2024)
      • Session Coverage
      • Presenter Profiles
      • Planning Resources
    • 83rd Scientific Sessions (2023)
      • Session Coverage
      • Presenter Profiles
      • Planning Resources
    • 82nd Scientific Sessions (2022)
      • Session Coverage
      • Presenter Profiles
      • Planning Resources
    • 81st Scientific Sessions (2021)
      • Session Coverage
      • Planning Resources
    • 80th Scientific Sessions (2020)
      • Planning Resources
      • Session Coverage
  • Online Planner
  • Mobile App & Online Planner
  • Schedule-at-a-Glance
  • Industry
    • Featured Industry Events
      • Corporate Symposia
      • Diabetes Learning Bytes
      • Product Theaters
    • Industry Connections
  • Mobile App
  • Scientific Sessions Home
  • Register Now
  • Get News Updates

The official news source of the 85th Scientific Sessions

JUNE 20–23, 2025 | CHICAGO, IL

The official news source of the
85th Scientific Sessions

JUNE 20–23, 2025 | CHICAGO, IL

Home » Scientific Sessions » 2025

  • Researchers to share weight loss results from bimagrumab and semaglutide combo
    May 9, 2025

    Researchers to share weight loss results from bimagrumab and semaglutide combo


    Steven B. Heymsfield, MD, Louis J. Aronne, MD, FACP, DABOM, and other panelists will explain insights into the treatment of obesity and overweight from BELIEVE.

  • Investigators to reveal full results from REDEFINE 1, 2 in Chicago
    May 9, 2025

    Investigators to reveal full results from REDEFINE 1, 2 in Chicago


    Melanie J. Davies, MB, ChB, MD, and other researchers will review data on combination therapy for weight loss using a fixed-dose combination of semaglutide and long-acting amylin analogue cagrilintide.

  • Symposium will explore next gen agents for type 2 diabetes and obesity
    May 9, 2025

    Symposium will explore next gen agents for type 2 diabetes and obesity


    Panelists including Dimitris Papamargaritis, MCRP, PhD, will discuss emerging therapies targeting the hormones glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), glucagon, and amylin.

  • Speakers to stress importance of preparing for heart failure ‘tidal wave’
    May 9, 2025

    Speakers to stress importance of preparing for heart failure ‘tidal wave’


    Adrian F. Hernandez, MD, MHS, and other experts will outline new developments in heart failure screening, prevention, and therapy related to diabetes.

  • Experts to explore using AI and diabetes tech to improve outcomes
    May 9, 2025

    Experts to explore using AI and diabetes tech to improve outcomes


    Panelists including Mindy Lee, MD, PhD, and Yaa Kumah-Crystal, MD, MPH, will review recent advancements in medical technology and artificial intelligence and their potential clinical implications.

  • Debate to weigh benefits and drawbacks of OTC CGMs
    May 9, 2025

    Debate to weigh benefits and drawbacks of OTC CGMs


    Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, and David Ahn, MD, will assess the impact of non-prescription use of continuous glucose monitors.

  • Hot topics in diabetes fill Scientific Sessions program
    May 2, 2025

    Hot topics in diabetes fill Scientific Sessions program


    Scientific Sessions Meeting Planning Committee Chair Mark A. Atkinson, PhD, highlights high-interest issues to be addressed by experts in the more than 200 sessions offered in Chicago.

  • Optimize your learning with innovative ideas and advance planning
    May 2, 2025

    Optimize your learning with innovative ideas and advance planning


    Attendees at the Scientific Sessions are invited to ask questions of the diverse faculty and share novel ideas while taking advantage of world-class education.

  • Register for the 85th Scientific Sessions in Chicago
    April 14, 2025

    Register for the 85th Scientific Sessions in Chicago


    Join the ADA for the world’s largest diabetes conference, taking place June 20–23 at the McCormick Place Convention Center. Advance registration rates are available through May 8.

  • Connect and initiate collaboration by networking
    April 14, 2025

    Connect and initiate collaboration by networking


    A variety of events—including receptions, the Poster Hall, and the Exhibit Hall—will help facilitate networking among attendees throughout the conference.

1 2
Next Page

View Archives

  • Select Year
    • 2025
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019

Popular Articles

  • ATTEMPT trial shows kidney, glycemic benefits for SGLT2 inhibitor in adolescents with type 1 diabetes


  • TIGHT investigators share lessons learned from evaluating inpatient CGM


  • FLOW trial demonstrates kidney, cardiovascular benefits of semaglutide in high-risk patients with type 2 diabetes


  • STEP trials show heart failure benefit with or without diabetes, could transform HFpEF treatment


  • New results from SELECT show reduction in progression to diabetes


  • SURMOUNT-OSA findings demonstrate benefit of tirzepatide in treatment of obesity-related OSA



© 2025 American Diabetes Association. All Rights Reserved. Powered By TriStar Event Media, LLC.

Privacy Policy

© 2025 American Diabetes Association. All Rights Reserved.
Powered By TriStar Event Media, LLC.

Privacy Policy

Get news updates from ADA Meeting News

Subscribe to get regular news updates about the Scientific Sessions.
You can also subscribe to receive other email communications from the American Diabetes Association.